Cetuximab for the treatment of patients with colorectal cancer
Author:
- 6 May 2008
- journal article
- editorial
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 5 (6) , 310-311
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicityAnnals of Oncology, 2008
- KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With CetuximabJournal of Clinical Oncology, 2008
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004